Azenta, Inc. AZTA

What this company does

Azenta provides biological and chemical compound sample exploration and management solutions for the life sciences industry, supporting customers from research and clinical development to commercialization with sample management and automated storage systems, as well as genomic services. As of September 30, 2025, it employed approximately 3,000 full-time, part-time and contingent workers worldwide and had sales in approximately 95 countries. It has approximately 14,000 customers globally. It operates a network of 14 laboratories that provide genomic services, including seven in the United States, three in China, two in the United Kingdom, and one each in Japan and Germany. Its two reportable segments are Sample Management Solutions, which offers end-to-end sample management products and services including Sample Repository Services and Core Products such as automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices; and Multiomics, which offers genomic and other sample analysis services including gene sequencing, gene synthesis and related services. As of November 20, 2025, it owned approximately 103 issued U.S. patents, with various corresponding patents issued in foreign jurisdictions, and approximately 545 foreign issued patents. Azenta, Inc. was founded in 1978; on December 1, 2021 it changed its corporate name from "Brooks Automation, Inc." to "Azenta, Inc."; and it divested the last of its semiconductor businesses in February 2022 for $2.9 billion in cash.

Written from the business description in AZENTA, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 4 December 2025. Every sentence was checked against that document before publication.